GSK1904529A|N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基..
| GSK1904529A|N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基)-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶基]咪唑并[1,2-A]吡啶-2-基]-2-甲氧基苯甲酰胺 基本信息 更多信息 |
中文名称: | N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基)-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶基]咪唑并[1,2-A]吡啶-2-基]-2-甲氧基苯甲酰胺 | 中文同义词: | N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基)-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶基]咪唑并[1,2-A]吡啶-2-基]-2-甲氧基苯甲酰胺;IGF-1R和IR抑制剂(GSK1904529A);N-(2,6-二氟苯基)-5-(3-(2-((5-乙基-2-甲氧基-4-(4-(4-(甲基磺酰基)哌嗪-1-基)哌啶-1-基))苯基)氨基)嘧啶-4-基)咪唑并[1,2-A]吡啶-2-基)-2-甲氧基苯甲酰胺;GSK1904529A,IGF-1R / IR酪氨酸激酶抑制剂;化合物 GSK1904529A | 英文名称: | GSK1904529A | 英文同义词: | GSK 4529;GSK1904529A;GSK1904529A : IGF-IR, IGF-IIR inhibitor;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide;N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)H-imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide GSK 1904529A;GSK1904529A, >=98%;IGF-IR, IGF-IIR inhibitor | CAS号: | 1089283-49-7 | 分子式: | C44H47F2N9O5S | 分子量: | 851.96 | EINECS号: | | |
|
按国家浏览GSK1904529A国外供应商 |
中国供应商 |
|
|
建议您优先选择企业会员,我们对企业会员产品有严格审核。 |
|
|